Replies to post #11341 on CryoPort Inc (CYRX)

[robertmaxwell]

I can imagine.

if it was not for the miracle called gene and cell therapy, would I even be replying?

Coming full circle to my previous point: For many financial investors this is a way to get exposure to the cutting edge. Sure, the portal is great and there are small applications elsewhere, but they don't care. This is a way to buy into cutting edge biopharma without idiosyncratic risk.